Skip to main content

Table 2 Summary of Patients Characteristics

From: Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET/CT in non-small cell lung Cancer

Variable

All patients (n = 112)

Median age (years)a

69 (32–85)

Sex, n (%)

 M

84 (75.0%)

 F

28 (25.0%)

Histologic subtype, n (%)

 Adenocarcinoma

72 (64.3%)

 Squamous cell carcinoma

28 (25.0%)

 Other

12 (10.7%)

TNM stage

 T1/T2/T3/T4

25 / 47 / 10 / 30

 N0/N1/N2/N3

29 / 13 / 41 / 29

 M0/M1

63 / 49

 Stage I / II / III / IV

16 / 1 / 47 / 48

Treatment, n (%)

 Chemotherapy

82 (73.2%)

 Surgery

21 (18.8%)

 Radiation

1 (0.9%)

 Surgery + Chemotherapy

8 (7.1%)

  1. aNumbers in parentheses are ranges